Tagatose is a naturally occurring monosaccharide classified as a rare sugar tagatose, gaining strong interest as a functional tagatose sweetener, low-calorie tagatose sweetener in food and beverage formulation. Tagatose sweeteners deliver approximately 90% of sucrose’s sweetness with 60% low calories sweetener tagatose, has a low glycaemic sweetener index that helps prevent blood glucose spikes, and closely mimics sucrose’s functional properties across applications. Naturally present in small amounts in dairy products and fruits and produced commercially through enzymatic conversion, tagatose is also Ketogenic Certified, Non-GMO Project Verified, and Plant-Based Certified, making it a versatile solution for manufacturers seeking clean-label, low-calorie sweetener, and gut-health-supporting tagatose sweetener systems without compromising taste or processing efficiency. [1] [2]
This table summarizes the key nutritional, metabolic, and functional attributes of tagatose sweetener that make it a preferred next-generation sweetener for health-focused food and custom supplement formulations.
Feature | Details |
Sweetness Intensity | ~90% as sweet as sucrose, allowing near one-to-one sugar replacement without taste compromise |
Caloric Value | Tagatose Provides ~60% low calories sweetener than sucrose, supporting low-calorie and reduced-energy formulations |
Glycaemic Index (GI) | Very low GI (~3); does not cause rapid blood glucose elevation |
Glycaemic Response | Minimal impact on blood glucose levels, making it suitable for blood sugar management |
Insulin Response | Does not significantly stimulate insulin secretion, supporting metabolic health |
Suitability for Diets | Appropriate for diabetic, low-glycaemic, ketogenic, and weight-management diets |
Functional Benefits | Acts as a prebiotic by nourishing beneficial gut bacteria; maintains sugar-like taste and texture |
Certifications | NutraStrong™ Prebiotic Verified, Ketogenic Certified, Non-GMO Project Verified, Plant-Based Certified |
Market Relevance | Aligns with growing consumer demand for functional sweetener tagatose, gut-health-supporting tagatose, lower-calorie sweeteners |
This table outlines the design, objectives, and key outcomes of a 2025 human clinical trial evaluating tagatose’s prebiotic potential and its effects on low glycaemic control and metabolic health of Tagatose. [4]
Category | Details |
Study Title | Effects of Tagatose on Glycaemic Response and Gut Microbiota |
Sponsor | PepsiCo Global R&D |
Study Type | Double-blind, randomized, controlled, cross-over clinical trial |
Study Period | March 25, 2025 – December 31, 2025 |
Participants | 55 healthy adults (18–50 years) with impaired fasting glucose and/or hyperinsulinemia |
BMI Range | 20.0–34.9 kg/m² |
Groups | Tagatose (10 g/day) vs. Placebo (sucrose, 10 g/day) |
Duration | 4 weeks per intervention |
Primary Objective | To evaluate whether tagatose acts as a prebiotic by selectively stimulating beneficial gut bacteria |
Secondary Objectives | Assess impact on oral glucose tolerance, insulin sensitivity, and blood glucose management |
Mechanism Studied | Colonic fermentation of tagatose → SCFA production → GLP-1 release → improved insulin function |
Key Findings (2025 Evidence) | Improved glycaemic control, enhanced beneficial gut microbiota, potential weight management benefits |
Additional Health Effects | Supports HDL cholesterol increase; antimicrobial activity beneficial for oral health |
Safety Profile | Generally safe; mild and transient GI effects (gas, diarrhea) reported |
Scientific Significance | Provides human clinical validation of tagatose’s prebiotic and metabolic benefits, beyond preclinical data |
Sweetener | Limit Allowed | Regulatory Status | Health/Label Claims Requirements |
Tagatose | No ADI, mild GI effects above 30g/serving | U.S. FDA: GRAS since 2001; EU: Novel food; JECFA: No ADI; Canada: Novel food | Scientific evidence required for low glycaemic and prebiotic claims per local guidelines |
Product Name: TAGATOSE Pure Granulated Prebiotic Sweetener
Product Description: A pure granulated tagatose sweetener that serves as a functional, low-calorie sugar replacement with prebiotic benefits. This product provides a sugar-like sweetness and texture while supporting digestive health. TAGATOSE functions as both a sweetener and gut-health ingredient that can be used in a variety of foods and beverages.
Product Form: Granulated powder — free-flowing, white crystals suitable for direct use in recipes and formulations.
Tagatose sweeteners is an innovative functional sweetener that offers a sugar-like taste with low-calorie benefits and prebiotic properties. Food Research Lab specializes in creating market-ready solutions by enhancing sweetness systems and ensuring digestive tolerance, processing durability, and regulatory compliance for beverages and functional foods. FRL assists brands in replacing sugar without compromising sensory experience while promoting gut health and blood sugar control. Utilizing clinical data and advanced strategies, FRL helps manufacturers create appealing and health-oriented sweetener solutions that align with contemporary consumer expectations.
Food Research Lab strives for excellence in new Food, Beverage and Nutraceutical Product Research and Development by offering cutting edge scientific analysis and expertise.